Andersons pediatric cardiology 1677
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.41 KB, 3 trang )
JAmCollCardiol.2016;67(12):1399–1409.
225.HarukiS,MinamiY,HagiwaraN.Strokeand
emboliceventsinhypertrophiccardiomyopathy:
riskstratificationinpatientswithoutatrial
fibrillation.Stroke.2016;47(4):936–942.
226.SakamotoN,SatoN,OikawaK,etal.Late
gadoliniumenhancementofcardiacmagnetic
resonanceimagingindicatesabnormalitiesof
time-domainT-wavealternansinhypertrophic
cardiomyopathywithventriculartachycardia.
HeartRhythm.2015;12(8):1747–1755.
227.RubinshteinR,GlocknerJF,OmmenSR,etal.
Characteristicsandclinicalsignificanceoflate
gadoliniumenhancementbycontrast-enhanced
magneticresonanceimaginginpatientswith
hypertrophiccardiomyopathy.CircHeartFail.
2010;3(1):51–58.
228.AdabagAS,MaronBJ,AppelbaumE,etal.
Occurrenceandfrequencyofarrhythmiasin
hypertrophiccardiomyopathyinrelationto
delayedenhancementoncardiovascular
magneticresonance.JAmCollCardiol.
2008;51(14):1369–1374.
229.MaronBJ,HenryWL,ClarkCE,etal.
Asymetricseptalhypertrophyinchildhood.
Circulation.1976;53(1):9–19.
230.YetmanAT,HamiltonRM,BensonLN,
McCrindleBW.Long-termoutcomeand
prognosticdeterminantsinchildrenwith
hypertrophiccardiomyopathy.JAmColl
Cardiol.1998;32(7):1943–1950.
231.MaronBJ,SpiritoP,AckermanMJ,etal.
Preventionofsuddencardiacdeathwith
implantablecardioverter-defibrillatorsin
childrenandadolescentswithhypertrophic
cardiomyopathy.JAmCollCardiol.
2013;61(14):1527–1535.
232.BharuchaT,LeeKJ,DaubeneyPE,etal.Sudden
deathinchildhoodcardiomyopathy:resultsfrom
along-termnationalpopulation-basedstudy.J
AmCollCardiol.2015;65(21):2302–2310.
233.CzosekRJ,JefferiesJL,KhouryPR,etal.
Arrhythmicburdenandambulatorymonitoring
ofpediatricpatientswithcardiomyopathy.
PacingClinElectrophysiol.2016;39(5):443–
451.
234.DeckerJA,RossanoJW,SmithEO,etal.Risk
factorsandmodeofdeathinisolated
hypertrophiccardiomyopathyinchildren.JAm
CollCardiol.2009;54(3):250–254.
235.RosminiS,BiaginiE,O'MahonyC,etal.
Relationshipbetweenaetiologyandleft
ventricularsystolicdysfunctioninhypertrophic
cardiomyopathy.Heart.2017;103(4):300–306.
236.DreznerJA,AckermanMJ,AndersonJ,etal.
Electrocardiographicinterpretationinathletes:
the‘Seattlecriteria.BrJSportsMed.
2013;47(3):122–124.
237.GuerrierK,AndersonJB,PrattJ,etal.
Correlationofprecordialvoltagestoleft
ventricularmassonechocardiogramin
adolescentpatientswithhypertrophic
cardiomyopathycomparedwiththatin
adolescentathletes.AmJCardiol.
2015;115(7):956–961.
238.MontgomeryJV,HarrisKM,CaseySA,
ZenovichAG,MaronBJ.Relationof
electrocardiographicpatternstophenotypic
expressionandclinicaloutcomeinhypertrophic
cardiomyopathy.AmJCardiol.2005;96(2):270–
275.
239.DriscollD,AllenHD,AtkinsDL,etal.
Guidelinesforevaluationandmanagementof
commoncongenitalcardiacproblemsininfants,
children,andadolescents.Astatementfor
healthcareprofessionalsfromthecommitteeon
congenitalcardiacdefectsofthecouncilon
cardiovasculardiseaseinthe.Circulation.
1994;90:2180–2188.
240.HongJH,SchaffHV,NishimuraRA,etal.Mitral
regurgitationinpatientswithhypertrophic
